EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Immunohistochemical Profiling of Immune Checkpoints in Chronic Hepatitis B Liver Tissue

João Panão-Costa iD, Rui Caetano Oliveira iD, Paulo Teixeira iD, Francisco Caramelo iD, Maria Augusta Cipriano, Olga Borges iD, Armando Carvalho iD

Pathogens · 2025

DOI: 10.3390/pathogens14060596 ↗

At a glance

Journal article in Pathogens, 2025. Written by João Panão-Costa and 6 co-authors. Institution: CNC-UC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal. Major MEDLINE topics: Hepatitis B, Chronic, Immune Checkpoint Proteins, Liver. 47 references. The full text is freely available (open access, CC BY 4.0). Funded by: European Regional Development Fund (ERDF), Centro 2020 Regional Operational Programme, Operational Programme for Competitiveness and Internationalisation and Portuguese national.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Chronic hepatitis B (CHB) remains a significant global health concern due to complications like cirrhosis and liver cancer. Immune cell exhaustion, characterized by increased suppressive molecules and inhibitory receptors, represents a critical feature of CHB. Understanding the mechanisms of hepatic immune exhaustion in CHB patients is imperative for the development of effective therapeutic interventions. In this study, we investigated the expression levels and histological distribution of various immune checkpoint receptors and ligands in liver biopsies obtained from CHB patients. Additionally, we aimed to evaluate potential concurrent overexpression of specific receptors and their association with clinical parameters such as ALT levels. Our analysis revealed that PD-1, PD-L1, CTLA-4, TIM-3, GAL-9, CD272, TIGIT, and 2B4 exhibited predominant localization in portal tracts and sinusoids. Furthermore, we observed a correlation between the expression of PD-1, TIM-3, and GAL-9 with ALT levels in CHB patients. Additionally, a strong relationship was identified between the expression of CD272 and TIGIT, as well as between GAL-9 and CTLA-4 within the studied population. Our findings underscore the significance of the TIM-3:GAL-9 pathway in the immunopathogenesis of CHB. This detailed analysis sets the stage for future combined immunotherapy strategies aimed at leveraging checkpoint receptors to enhance clinical outcomes.

Subjects

MeSH terms (MEDLINE)

Hepatitis B, ChronicImmune Checkpoint ProteinsLiverHumansMaleFemaleAdultHepatitis A Virus Cellular Receptor 2Middle AgedReceptors, ImmunologicImmunohistochemistryProgrammed Cell Death 1 ReceptorGalectinsB7-H1 AntigenCTLA-4 AntigenHepatitis B virus

Author keywords

CTLA-4PD-1TIM-3chronic hepatitis Bimmune checkpoint blockadeimmune checkpoint inhibitorsimmune checkpoint receptorsimmune exhaustionimmunohistochemistryimmunotherapy

Substances

Immune Checkpoint ProteinsHepatitis A Virus Cellular Receptor 2HAVCR2 protein, humanReceptors, ImmunologicProgrammed Cell Death 1 ReceptorPDCD1 protein, humanGalectinsLGALS9 protein, humanB7-H1 AntigenTIGIT protein, human

Authors and institutions

  • CNC-UC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.
  • CIBB-Center for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal.
  • Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.
  • Department of Pathology, Centro Hospitalar e Universitário de Coimbra, 3000-075 Coimbra, Portugal.
  • Institute of Histology, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.
  • Institute for Clinical and Biomedical Research (iCBR): Environment, Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.

ORCID profiles: João Panão-Costa, Rui Caetano Oliveira, Paulo Teixeira, Francisco Caramelo, Olga Borges, Armando Carvalho

Funding

  • European Regional Development Fund (ERDF)
  • Centro 2020 Regional Operational Programme
  • Operational Programme for Competitiveness and Internationalisation and Portuguese national
  • 2021 APEF/MSD Research Grant
  • Internationalisation and Portuguese national funds via FCT—Fundação para a Ciência e a Tecnologia

Cite

APA

Panão-Costa, J., Oliveira, R. C., Teixeira, P., Caramelo, F., Cipriano, M. A., Borges, O., & Carvalho, A. (2025). Immunohistochemical Profiling of Immune Checkpoints in Chronic Hepatitis B Liver Tissue. Pathogens. https://doi.org/10.3390/pathogens14060596

Vancouver

Panão-Costa J, Oliveira RC, Teixeira P, Caramelo F, Cipriano MA, Borges O, et al. Immunohistochemical Profiling of Immune Checkpoints in Chronic Hepatitis B Liver Tissue. Pathogens. 2025. doi:10.3390/pathogens14060596

BibTeX
@article{PanoCosta2025,
  author = {Panão-Costa, João and Oliveira, Rui Caetano and Teixeira, Paulo and Caramelo, Francisco and Cipriano, Maria Augusta and Borges, Olga and Carvalho, Armando},
  title = {Immunohistochemical Profiling of Immune Checkpoints in Chronic Hepatitis B Liver Tissue},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14060596}
}
Start for free →